Cyrus Biotechnology, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2026-05-08. The offering totals $3.0M, of which $1.5M was reported sold. Industry: Biotechnology.
Showing 25 of 26 people.
| Name | Role | Location |
|---|---|---|
| Mark Benjamin | Related Person | SEATTLE, WA |
| Anthony Manning | Related Person | SEATTLE, WA |
| Lucas Nivon | Related Person | SEATTLE, WA |
| Ramakrishna Satyavolu | Related Person | SEATTLE, WA |
| Jason Smith | Related Person | EXTON, PA |
| Yifan Song | Related Person | SEATTLE, WA |
| Chad Waite | Related Person | SEATTLE, WA |
| Jason Smith | Director | EXTON, PA |
| Javier Castellanos | Director | Seattle, WA |
| Javier Castellanos | Executive Officer | Seattle, WA |
| Javier Castellanos | Promoter | Seattle, WA |
| Yifan Song | Director | SEATTLE, WA |
| Yifan Song | Executive Officer | SEATTLE, WA |
| Yifan Song | Promoter | SEATTLE, WA |
| Mark Benjamin | Executive Officer | SEATTLE, WA |
| Anthony Manning | Director | SEATTLE, WA |
| Lucas Nivon | Director | SEATTLE, WA |
| Lucas Nivon | Executive Officer | SEATTLE, WA |
| Lucas Nivon | Promoter | SEATTLE, WA |
| Ramakrishna Satyavolu | Director | SEATTLE, WA |
| Chad Waite | Director | SEATTLE, WA |
| Eric Bell | Director | Mountain View, CA |
| Gus Tai | Director | Long Island City, NY |
| Nivon Lucas | Director | Seattle, WA |
| Nivon Lucas | Executive Officer | Seattle, WA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-07-16 | D | $1.5M | $1.1M |
| 2024-12-31 | D | $3.5M | $3.2M |
| 2024-02-29 | D | $4.0M | $2.7M |
| 2021-12-02 | D/A | $19.4M | $18.4M |
| 2021-10-06 | D/A | $15.9M | $15.9M |
| 2021-07-07 | D | $12.9M | $9.1M |
| 2020-09-17 | D | $1.5M | $1.1M |
| 2017-07-27 | D | $8.0M | $8.0M |
| 2017-02-21 | D | $1.3M | $1.0M |
| 2016-11-16 | D | $500K | $490K |
| 2016-04-06 | D | $575K | $535K |
| 2015-05-06 | D | $850K | $850K |